Susannah Gray insider trades
Open-market stock purchases and sales by Susannah Gray, Unknown at Theravance Biopharma, Inc, from SEC Form 4 filings since Nov 19, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -76%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $322K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $241K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $224K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $228K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $223K |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Jun 17, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| May 26, 2026 | MRVI Maravai Lifesciences Holdings, Inc | Bought (not open market) | — |
| Apr 27, 2026 | ANAB Anaptysbio, Inc | Bought (not open market) | — |
Companies traded
- TBPH Theravance Biopharma, Inc: other filings, last Sep 23, 2026
- FDMT 4D Molecular Therapeutics, Inc: other filings, last Jun 17, 2026
- MRVI Maravai Lifesciences Holdings, Inc: 1 buy, last May 26, 2026
- ANAB Anaptysbio, Inc: other filings, last Apr 27, 2026
- MORF Morphic Holding, Inc: other filings, last Aug 16, 2024
- FMDT 4D Molecular Therapeutics, Inc: other filings, last May 23, 2023
- APR Apria, Inc: other filings, last Mar 29, 2022